LRRK2 and human disease: A complicated question or a question of complexes?

Science Signaling

Volumn 5, Issue 207, 2012, Pages

  Lewis, Patrick A ^a   Manzoni, Claudia ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; LRRK2 PROTEIN, HUMAN; LRRK2 PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE;

CROHN DISEASE; ENZYME ACTIVITY; GENE MUTATION; HUMAN; KNOCKOUT MOUSE; LEPROSY; NEOPLASM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ARTICLE; BIOLOGICAL MODEL; DISEASE MODEL; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; MOUSE MUTANT; NERVE CELL; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

MUS;

ANIMALS; CROHN DISEASE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MODELS, GENETIC; NEURONS; PARKINSON DISEASE; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 84856070973     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2002680     Document Type: Review

References (24)

1. C. Paisán-Ruíz, S. Jain, E. W. Evans, W. P. Gilks, J. Simón, M. van der Brug, A. López de Munain, S. Aparicio, A. M. Gil, N. Khan, J. Johnson, J. R. Martinez, D. Nicholl, I. M. Carrera, A. S. Pena, R. de Silva, A. Lees, J. F. Martí-Massó, J. Pérez-Tur, N. W.Wood, A. B. Singleton, Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595-600 (2004).
2. A. Zimprich, S. Biskup, P. Leitner, P. Lichtner, M. Farrer, S. Lincoln, J. Kachergus, M. Hulihan, R. J. Uitti, D. B. Calne, A. J. Stoessl, R. F. Pfeiffer, N. Patenge, I. C. Carbajal, P. Vieregge, F. Asmus, B. Müller-Myhsok, D. W. Dickson, T. Meitinger, T. M. Strom, Z. K. Wszolek, T. Gasser, Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601-607 (2004).
3. F. R. Zhang, W. Huang, S. M. Chen, L. D. Sun, H. Liu, Y. Li, Y. Cui, X. X. Yan, H. T. Yang, R. D. Yang, T. S.Chu, C. Zhang, L. Zhang, J. W.Han, G. Q.Yu, C. Quan, Y. X. Yu, Z. Zhang, B. Q. Shi, L. H. Zhang, H. Cheng, C. Y. Wang, Y. Lin, H. F. Zheng, X. A. Fu, X. B. Zuo, Q. Wang, H. Long, Y. P. Sun, Y. L. Cheng, H. Q. Tian, F. S. Zhou, H. X. Liu, W. S. Lu, S. M. He, W. L. Du, M. Shen, Q. Y. Jin, Y. Wang, H. Q. Low, T. Erwin, N. H.Yang, J. Y. Li, X. Zhao, Y. L. Jiao, L. G. Mao, G. Yin, Z. X. Jiang, X. D. Wang, J. P.Yu, Z. H. Hu, C. H. Gong, Y. Q. Liu, R. Y. Liu, D. M. Wang, D. Wei, J. X. Liu, W. K. Cao, H. Z. Cao, Y. P. Li, W. G.Yan, S. Y.Wei, K. J.Wang, M. L. Hibberd, S. Yang, X. J. Zhang, J. J. Liu, Genomewide association study of leprosy. N. Engl. J. Med. 361, 2609-2618 (2009).
4. M. A. Nalls, V. Plagnol, D. G. Hernandez, M. Sharma, U. M. Sheerin, M. Saad, J. Simón-Sánchez, C. Schulte, S. Lesage, S. Sveinbjörnsdóttir, K. Stefánsson, M. Martinez, J. Hardy, P. Heutink, A. Brice, T. Gasser, A. B. Singleton, N. W. Wood; International Parkinson Disease Genomics Consortium, Imputation of sequence variants for identification of genetic risks for Parkinson's disease: A meta-analysis of genome-wide association studies. Lancet 377, 641-649 (2011).
5. A. Franke, D. P. McGovern, J. C. Barrett, K. Wang, G. L. Radford-Smith, T. Ahmad, C. W. Lees, T. Balschun, J. Lee, R. Roberts, C. A. Anderson, J. C. Bis, S. Bumpstead, D. Ellinghaus, E. M. Festen, M. Georges, T. Green, T. Haritunians, L. Jostins, A. Latiano, C. G. Mathew, G. W. Montgomery, N. J. Prescott, S. Raychaudhuri, J. I. Rotter, P. Schumm, Y. Sharma, L. A. Simms, K. D. Taylor, D. Whiteman, C. Wijmenga, R. N. Baldassano, M. Barclay, T. M. Bayless, S. Brand, C. Büning, A. Cohen, J. F. Colombel, M. Cottone, L. Stronati, T. Denson, M. De Vos, R. D'Inca, M. Dubinsky, C. Edwards, T. Florin, D. Franchimont, R. Gearry, J. Glas, A. Van Gossum, S. L. Guthery, J. Halfvarson, H. W. Verspaget, J. P. Hugot, A. Karban, D. Laukens, I. Lawrance, M. Lemann, A. Levine, C. Libioulle, E. Louis, C. Mowat, W. Newman, J. Panés, A. Phillips, D. D. Proctor, M. Regueiro, R. Russell, P. Rutgeerts, J. Sanderson, M. Sans, F. Seibold, A. H. Steinhart, P. C. Stokkers, L. Torkvist, G. Kullak-Ublick, D. Wilson, T. Walters, S. R. Targan, S. R. Brant, J. D. Rioux, M. D'Amato, R. K. Weersma, S. Kugathasan, A. M. Griffiths, J. C. Mansfield, S. Vermeire, R. H. Duerr, M. S. Silverberg, J. Satsangi, S. Schreiber, J. H. Cho, V. Annese, H. Hakonarson, M. J. Daly, M. Parkes, Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42, 1118-1125 (2010).
6. S. Hassin-Baer, Y. Laitman, E. Azizi, I. Molchadski, G. Galore-Haskel, F. Barak, O. S. Cohen, E. Friedman, The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel. J. Neurol. 256, 483-487 (2009).
7. O. A. Ross, A. I. Soto-Ortolaza, M. G. Heckman, J. O. Aasly, N. Abahuni, G. Annesi, J. A. Bacon, S. Bardien, M. Bozi, A. Brice, L. Brighina, C. Van Broeckhoven, J. Carr, M. C. Chartier-Harlin, E. Dardiotis, D. W. Dickson, N. N. Diehl, A. Elbaz, C. Ferrarese, A. Ferraris, B. Fiske, J. M. Gibson, R. Gibson, G. M. Hadjigeorgiou, N. Hattori, J. P. Ioannidis, B. Jasinska-Myga, B. S. Jeon, Y. J. Kim, C. Klein, R. Kruger, E. Kyratzi, S. Lesage, C. H. Lin, T. Lynch, D. M. Maraganore, G. D. Mellick, E. Mutez, C. Nilsson, G. Opala, S. S. Park, A. Puschmann, A. Quattrone, M. Sharma, P. A. Silburn, Y. H. Sohn, L. Stefanis, V. Tadic, J. Theuns, H. Tomiyama, R. J. Uitti, E. M. Valente, S. van de Loo, D. K. Vassilatis, C. Vilariño-Güell, L. R. White, K. Wirdefeldt, Z. K. Wszolek, R. M. Wu, M. J. Farrer; Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium, Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: A case-control study. Lancet Neurol. 10, 898-908 (2011).
8. C. Greenman, P. Stephens, R. Smith, G. L. Dalgliesh, C. Hunter, G. Bignell, H. Davies, J. Teague, A. Butler, C. Stevens, S. Edkins, S. O'Meara, I. Vastrik, E. E. Schmidt, T. Avis, S. Barthorpe, G. Bhamra, G. Buck, B. Choudhury, J. Clements, J. Cole, E. Dicks, S. Forbes, K. Gray, K. Halliday, R. Harrison, K. Hills, J. Hinton, A. Jenkinson, D. Jones, A. Menzies, T. Mironenko, J. Perry, K. Raine, D. Richardson, R. Shepherd, A. Small, C. Tofts, J. Varian, T. Webb, S. West, S. Widaa, A. Yates, D. P. Cahill, D. N. Louis, P. Goldstraw, A. G. Nicholson, F. Brasseur, L. Looijenga, B. L. Weber, Y. E. Chiew, A. DeFazio, M. F. Greaves, A. R. Green, P. Campbell, E. Birney, D. F. Easton, G.Chenevix-Trench, M. H. Tan, S. K. Khoo, B. T. Teh, S. T. Yuen, S. Y. Leung, R. Wooster, P. A. Futreal, M. R. Stratton, Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158 (2007).
9. Z. Liu, J. Lee, S. Krummey, W. Lu, H. Cai, M. J. Lenardo, The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat. Immunol. 12, 1063-1070 (2011).
10. D. Z. Wang, P. G. McCaffrey, A. Rao, The cyclo-sporin-sensitive transcription factor NFATp is expressed in several classes of cells in the immune system. Ann. N.Y. Acad. Sci. 766 (1 Receptor Acti), 182-194 (1995).
11. A. Gardet, Y. Benita, C. Li, B. E. Sands, I. Ballester, C. Stevens, J. R. Korzenik, J. D. Rioux, M. J. Daly, R. J. Xavier, D. K. Podolsky, LRRK2 is involved in the IFN-gamma response and host response to pathogens. J. Immunol. 185, 5577-5585 (2010).
12. J. Thévenet, R. Pescini Gobert, R. Hooft van Huijsduijnen, C. Wiessner, Y. J. Sagot, Regulation of LRRK2 expression points to a functional role in human monocyte maturation. PLoS ONE 6, e21519 (2011).
13. M. R. Cookson, The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Nat. Rev. Neurosci. 11, 791-797 (2010).
14. B. Jabri, L. B. Barreiro, Don't move: LRRK2 arrests NFAT in the cytoplasm. Nat. Immunol. 12, 1029-1030 (2011).
15. N. Shin, H. Jeong, J. Kwon, H. Y. Heo, J. J. Kwon, H. J. Yun, C. H. Kim, B. S. Han, Y. Tong, J. Shen, T. Hatano, N. Hattori, K. S. Kim, S. Chang, W. Seol, LRRK2 regulates synaptic vesicle endocytosis. Exp. Cell Res. 314, 2055-2065 (2008).
16. G. Piccoli, S. B. Condliffe, M. Bauer, F. Giesert, K. Boldt, S. De Astis, A. Meixner, H. Sarioglu, D. M. Vogt-Weisenhorn, W. Wurst, C. J. Gloeckner, M. Matteoli, C. Sala, M. Ueffing, LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool. J. Neurosci. 31, 2225-2237 (2011).
17. Y. Imai, S. Gehrke, H. Q. Wang, R. Takahashi, K. Hasegawa, E. Oota, B. Lu, Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J. 27, 2432-2443 (2008).
18. B. D. Looyenga, K. A. Furge, K. J. Dykema, J. Koeman, P. J. Swiatek, T. J. Giordano, A. B. West, J. H. Resau, B. T. Teh, J. P. MacKeigan, Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas. Proc. Natl. Acad. Sci. U.S.A. 108, 1439-1444 (2011).
19. F. Gillardon, Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability - a point of convergence in parkinsonian neurodegeneration? J. Neurochem. 110, 1514-1522 (2009).
20. D. C. Berwick, K. Harvey, LRRK2 signaling pathways: the key to unlocking neurodegeneration? Trends Cell Biol. 21, 257-265 (2011).
21. J. Alegre-Abarrategui, H. Christian, M. M. Lufino, R. Mutihac, L. L. Venda, O. Ansorge, R. Wade- Martins, LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum. Mol. Genet. 18, 4022-4034 (2009).
22. P. A. Lewis, The function of ROCO proteins in health and disease. Biol. Cell 101, 183-191 (2009).
23. D. D. Sarbassov, S. M. Ali, D. M. Sabatini, Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17, 596-603 (2005).
24. C. L. Dahlberg, E. Z. Nguyen, D. Goodlett, D. Kimelman, Interactions between Casein kinase Iepsilon (CKIepsilon) and two substrates from disparate signaling pathways reveal mechanisms for substrate-kinase specificity. PLoS ONE 4, e4766 (2009).